I am pleased to announce the initiation of our new blog, which will allow our patients to stay informed on the latest advances and other news in Facial Plastic Surgery. I will be posting articles and other entries that help to ensure that you are exceedingly well-prepared for any procedure, and keep you updated on new developments and specials here at Donath Facial Plastic Surgery. Importantly, I also encourage each of you to submit anything you might be interested in, including any articles, questions, or comments about recent developments. Having a running dialogue like this is a fantastic and stimulating way to learn more about how to get the best results and the best bang for your buck!
To kick things off, those of you who have been asking about alternatives to Botox will be happy to know that the long-awaited competitor, Reloxin (to be distributed by Medicis, the makers of Restylane and Perlane), is finally under review by the FDA. It’s impossible to predict when exactly the review will be completed, but I will let you know as soon as I do. The Botox brand has had a monopoly on this market in the U.S. for years now, and we welcome the prospect of competition in this area to stabilize, or even improve, the affordability for all of our patients.
I also have a backlog of interesting articles I’ve accumulated over just the past few months. I’ll start with this one from the front page of the Enquirer–it’s a very well-written article. Please also see my reply to the author, pointing out the benefits of Fat Transfer for a more long-lasting effect of Volume Replacement in the face.